Diversity among clinical trial participants allows studies to assess drug safety and efficacy in a population representative of the people who will ultimately receive approved treatments.
Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoint inhibitors, or ICIs,…
Volunteers from the Association for Clinical Oncology (ASCO) were on Capitol Hill on April 17 for the 2024 ASCO Advocacy Summit where they met with…
What would you do if your doctor told you they knew how to treat your cancer, but couldn’t get the medicine to do so?
What would you do if your doctor told you they knew how to treat your cancer, but couldn’t get the medicine to do so?
PURPOSE Denosumab is clinically superior to zoledronic acid (ZA) for preventing and delaying time to first and subsequent skeletal-related events (SREs) among patients with breast…
The Association for Clinical Oncology (ASCO) is holding its annual Advocacy Summit Week of Action from April 15-19, during which ASCO members are encouraged to…
